Don Kakuda

Neurotide is a spin-off company from The University of Queensland's commercial arm, UniQuest Pty Ltd. The company's research is led by UQ's Professor Istvan Toth and Dr Joanne Blanchfield, who are creating an oral pharmaceutical for pain. They are demonstrating that the drug can relieve pain in vivo. If this research is successful, the company will move towards human trials. Investors are sought to help them continue development. They hope to access the international market for pain drugs, and are particularly targeting the neuropathic pain market.

Neurotide is a spin-off company from The University of Queensland's commercial arm, UniQuest Pty Ltd. The company's research is led by UQ's Professor Istvan Toth and Dr Joanne Blanchfield, who are creating an oral pharmaceutical for pain. They are demonstrating that the drug can relieve pain in vivo. If this research is successful, the company will move towards human trials. Investors are sought to help them continue development. They hope to access the international market for pain drugs, and are particularly targeting the neuropathic pain market.

UniQuest Pty Ltd. operates as a commercialization company of The University of Queensland. It specializes in industry-university collaborations, global technology transfer, and provide access to UQ's world-class expertise, intellectual property, and facilities. The company was founded in July 1984 and is headquartered in Brisbane, Australia.

Neurotide is a spin-off company from The University of Queensland's commercial arm, UniQuest Pty Ltd. The company's research is led by UQ's Professor Istvan Toth and Dr Joanne Blanchfield, who are creating an oral pharmaceutical for pain. They are demonstrating that the drug can relieve pain in vivo. If this research is successful, the company will move towards human trials. Investors are sought to help them continue development. They hope to access the international market for pain drugs, and are particularly targeting the neuropathic pain market.